Trial intelligence / Profile preview

Amlodipine/Valsartan Single-Pill Combination in Hypertension

NCT02058446Phase 4Completed

Sponsor
TSH Biopharm Corporation Limited
Start
Oct 2013
Primary completion
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amlodipine, valsartan in essential hypertension, sponsored by TSH Biopharm Corporation Limited. Started Oct 2013; status: completed.

02

Drugs

amlodipinevalsartan
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT02058446.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02058446.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call